A Nutrition and Exercise Lifestyle Intervention Program Participant Choice Approach
Launched by WESTERN UNIVERSITY, CANADA · Dec 18, 2023
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how giving pregnant women a choice in their nutrition and exercise plans can help them stick to those plans and maintain a healthy weight during pregnancy. The researchers want to find out if allowing women to choose how and when to introduce nutrition and exercise components makes it easier for them to follow the program compared to a standard approach where the interventions are assigned. Participants will be divided into three groups: one group will start both nutrition and exercise right away, while the other two groups will introduce these components at different times. The study will follow participants until they give birth and check on their health at several points after delivery.
To participate in this trial, women need to be between 12 to 18 weeks pregnant and expecting one baby. They also need to pass a health screening to ensure they can safely exercise. Unfortunately, women with serious health issues, like uncontrolled high blood pressure or diabetes, and those who can’t walk will not be eligible. Participants can expect to receive support for their nutrition and exercise routines and will be monitored to see how these choices impact their pregnancy health. This study aims to make pregnancy healthier for women by finding better ways to encourage them to stay active and eat well.
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • between 12 to 18 weeks of pregnancy
- • a singleton fetus
- • medically screened with the Get Active Questionnaire for Pregnancy to determine eligibility for participation in the exercise component
- Exclusion Criteria:
- • inability to walk
- • serious medical problems
- • high blood pressure
- • uncontrolled chest pain
- • uncontrolled symptomatic lung disease
- • diabetes before pregnancy
- • a history of recreational substance use disorder
- • any contraindication to exercise
- • enrolled in another clinical trial.
About Western University, Canada
Western University, located in Canada, is a leading research institution committed to advancing healthcare through innovative clinical trials. With a strong emphasis on interdisciplinary collaboration, the university harnesses the expertise of its faculty and research teams to conduct high-quality studies that address pressing medical challenges. Western University is dedicated to fostering a culture of ethical research practices, ensuring participant safety, and generating impactful findings that contribute to evidence-based medicine and improve patient outcomes. Through its robust infrastructure and commitment to excellence, Western University plays a vital role in the field of clinical research.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
London, Ontario, Canada
Patients applied
Trial Officials
Michelle F Mottola, PhD
Principal Investigator
Western University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported